Device
cryoballoon ablation system
cryoballoon ablation system is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completedphase_4
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT01803438
active_not_recruitingnot_applicable
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
NCT02514525
completednot_applicable
Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy
NCT02729727
Clinical Trials (3)
Showing 3 of 3 trials
NCT01803438Phase 4
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT02514525Not Applicable
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
NCT02729727Not Applicable
Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3